- Survival Benefit of Transplantation with a Deceased Diabetic Donor Kidney Compared with Remaining on the Waitlist Cohen JB, Eddinger KC, Locke JE, Forde KA, Reese PP, Sawinski DL. Clin J Am Soc Nephrol. 2017 Jun 7;12(6):974-982
- The Authors Reply Locke JE, Reed RD, Massie AB, Segev DL. Kidney Int. 2017 May;91(5):1256.
- Access to Kidney Transplantation among HIV-Infected Waitlist Candidates Locke JE, Mehta S, Sawinski D, Gustafson S, Shelton BA, Reed RD, MacLennan P, Bolch C, Durand C, Massie A, Mannon RB, Gaston R, Saag M, Overton T, Segev DL. Clin J Am Soc Nephrol. 2017 Mar 7;12(3):467-475
- Survival Benefit of Kidney Transplantation in HIV-infected Patients
Locke, J. E., Gustafson, S., Mehta, S., Reed, R. D., Shelton, B., MacLennan, P. A., … Segev, D. L. (2017). Survival Benefit of Kidney Transplantation in HIV-Infected Patients. Annals of Surgery, 265(3), 604–608.
- Abdominal lean muscle is associated with lower mortality among kidney waitlist candidates Locke JE, Carr JJ, Nair S, Terry JG, Reed RD, Smith GD, Segev DL, Kumar V, Lewis CE. Clin Transplant. 2017 Mar;31(3)
- Obesity increases the risk of end-stage renal disease among living kidney donors Locke JE, Reed RD, Massie A, MacLennan PA, Sawinski D, Kumar V, Mehta S, Mannon RB, Gaston R, Lewis CE, Segev DL. Kidney Int. 2017 Mar;91(3):699-703
- Lymphocyte-depleting induction therapy lowers the risk of acute rejection in African American pediatric kidney transplant recipients Crowson CN, Reed RD, Shelton BA, MacLennan PA, Locke JE. Pediatr Transplant. 2017 Feb;21(1).
- Increased Mortality and Graft Loss With Kidney Retransplantation Among Human Immunodeficiency Virus (HIV)-Infected Recipients Shelton BA, Mehta S, Sawinski D, Reed RD, MacLennan PA, Gustafson S, Segev DL, Locke JE. Am J Transplant. 2017 Jan;17(1):173-179
- Kidney transplantation of highly sensitized recipients under the new kidney allocation system: A reflection from five different transplant centers across the United States Parsons RF, Locke JE, Redfield RR 3rd, Roll GR, Levine MH. Hum Immunol. 2017 Jan;78(1):30-36
- Dosing Eculizumab for Antibody-Mediated Rejection in Kidney Transplantation: A Case Report Smith B, Kumar V, Mompoint-Williams D, Reed RD, MacLennan PA, Stegner K, Locke JE. Transplant Proc. 2016 Nov;48(9):3099-3105.
- Insurance Type and Solid Organ Transplantation Outcomes: A Historical Perspective on How Medicaid Expansion Might Impact Transplantation Outcomes DuBay DA, MacLennan PA, Reed RD, Shelton BA, Redden DT, Fouad M, Martin MY, Gray SH, White JA, Eckhoff DE, Locke JE. J Am Coll Surg. 2016 Oct;223(4):611-620.e4
- Identification of Optimal Donor-Recipient Combinations Among Human Immunodeficiency Virus (HIV)-Positive Kidney Transplant RecipientsLocke JE, Shelton BA, Reed RD, MacLennan PA, Mehta S, Sawinski D, Segev DL. Am J Transplant. 2016 Aug;16(8):2377-83
- Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency VirusKucirka LM, Durand CM, Bae S, Avery RK, Locke JE, Orandi BJ, McAdams-DeMarco M, Grams ME, Segev DL. Am J Transplant. 2016 Aug;16(8):2368-76
- Login
- |
- Privacy
- |
- Terms of Use
- |
- © 2024 The University of Alabama at Birmingham
UAB is an Equal Employment/Equal Educational Opportunity Institution dedicated to providing equal opportunities and equal access to all individuals regardless of race, color, religion, ethnic or national origin, sex (including pregnancy), genetic information, age, disability, religion, sexual orientation, gender identity, gender expression, and veteran’s status. As required by Title IX, UAB prohibits sex discrimination in any education program or activity that it operates. Individuals may report concerns or questions to UAB’s Assistant Vice President and Senior Title IX Coordinator. The Title IX notice of nondiscrimination is located at uab.edu/titleix.